Detalles de la búsqueda
1.
Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy.
Am J Hematol
; 99 Suppl 1: S19-S27, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425173
2.
A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Breast Cancer Res Treat
; 168(2): 371-379, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29214415
3.
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
Breast Cancer Res
; 19(1): 54, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464908
4.
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 160(1): 17-28, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27632288
5.
Implementing Next-Generation Sequencing Process Changes to Increase Capacity and Improve Timeliness of Molecular Biomarker Profiling for Lung Cancer Patients.
J Appl Lab Med
; 9(2): 284-294, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102066
6.
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.
Curr Oncol
; 31(3): 1278-1290, 2024 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534929
7.
Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature.
Immunotherapy
; 15(5): 323-333, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852421
8.
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
J Thorac Oncol
; 17(3): 434-445, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800700
9.
A case of successful pembrolizumab rechallenge in a patient with non-small-cell lung cancer and grade 3 dermatomyositis.
Immunotherapy
; 13(6): 477-481, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626928
10.
Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario.
Curr Oncol
; 28(3): 2190-2198, 2021 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34204717
11.
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer.
Curr Oncol
; 28(3): 1847-1856, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34068083
12.
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer.
J Bone Oncol
; 30: 100388, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34567960
13.
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
J Bone Oncol
; 26: 100343, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425673
14.
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.
Eur J Cancer
; 142: 132-140, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023785
15.
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
J Natl Cancer Inst
; 113(2): 192-198, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527137
16.
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.
Lung Cancer
; 143: 1-11, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32169783
17.
Improving Timeliness of Oncology Assessment and Cancer Treatment Through Implementation of a Multidisciplinary Lung Cancer Clinic.
J Oncol Pract
; 15(2): e169-e177, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30615586
18.
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers.
J Clin Oncol
; 37(12): 992-1000, 2019 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30785829
19.
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy.
Lung Cancer
; 120: 142-148, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748010
20.
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol
; 35(18): 2062-2081, 2017 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618241